0001209191-18-041006.txt : 20180703
0001209191-18-041006.hdr.sgml : 20180703
20180703161645
ACCESSION NUMBER: 0001209191-18-041006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180629
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18937331
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2018-06-29
4
M
0
859
96.87
A
16946
D
Common Stock
2018-06-29
4
S
0
859
171.87
D
16087
D
Common Stock
2018-06-29
4
M
0
1289
91.05
A
17376
D
Common Stock
2018-06-29
4
S
0
1289
166.05
D
16087
D
Common Stock
2018-06-29
4
M
0
809
86.52
A
16896
D
Common Stock
2018-06-29
4
S
0
809
161.57
D
16087
D
Common Stock
169
I
401(k)
Stock Option (Right to Buy)
96.87
2018-06-29
4
M
0
859
0.00
D
2024-07-14
Common Stock
859
860
D
Stock Option (Right to Buy)
91.05
2018-06-29
4
M
0
1289
0.00
D
2026-02-01
Common Stock
1289
9024
D
Stock Option (Right to Buy)
86.52
2018-06-29
4
M
0
809
0.00
D
2027-02-02
Common Stock
809
8899
D
Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 07/15/2014.
The option vests in 16 quarterly installments from 02/02/2016.
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Stephen Migausky, Attorney-in-Fact
2018-07-03